Mary Madison, RN, RAC-CT, CDP
Clinical Consultant – Briggs Healthcare
ASPR, in partnership with the Johns Hopkins University Applied Physics Laboratory, has developed the COVID-19 Monoclonal Antibody Therapeutics Calculator for Infusion Sites (mAbs Calculator). The mAbs Calculator is a free, data-informed decision support tool that is based on a comprehensive simulation framework. The mAbs Calculator can be used to inform staffing decisions and resource investments needed for COVID-19 monoclonal antibody therapeutic infusion sites.
The mAbs Calculator was developed using advanced simulation and modeling tools in real-time to inform the implementation of mAb treatments. More than 162,000 alternative scenarios that take into account staffing and capacity levels, scheduling protocols, patient demand, facility service hours, and infusion durations were considered in the development of this tool.
Administration of COVID-19 mAb therapeutics can help reduce the strain on hospital systems by decreasing the need for hospitalization of high-risk COVID-19 patients with mild to moderate symptoms, and FDA recommends IV administration of these treatments. A wide range of clinical settings have implemented mAb infusion sites, including large heath care systems, emergency departments, medical sites, rural health providers, ambulatory care facilities, long-term care facilities, urgent care sites, and federally qualified health sites.
The mAbs Calculator can help hospitals and health care facilities: